Alliance Pharma plc (LON:APH – Get Rating)’s share price passed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 106.15 ($1.28) and traded as low as GBX 73.60 ($0.89). Alliance Pharma shares last traded at GBX 74.20 ($0.90), with a volume of 602,208 shares trading hands.
Wall Street Analysts Forecast Growth
Several equities analysts recently issued reports on the company. Royal Bank of Canada reissued an “outperform” rating and set a GBX 130 ($1.57) target price on shares of Alliance Pharma in a research note on Monday, August 8th. Berenberg Bank reissued a “buy” rating and set a GBX 145 ($1.75) price target on shares of Alliance Pharma in a research report on Thursday, July 14th.
Alliance Pharma Stock Down 1.2 %
The company has a quick ratio of 1.40, a current ratio of 2.00 and a debt-to-equity ratio of 42.11. The stock has a market cap of £400.55 million and a price-to-earnings ratio of 7,420.00. The business’s fifty day moving average is GBX 93.64 and its two-hundred day moving average is GBX 106.15.
About Alliance Pharma
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products.
- Oracle’s Short-Term Pain Could Be Your Long-Term Gain
- Lucid is Looking Like a Clear EV Winner
- Still Lovin’ It: Investors Keep Visiting McDonald’s
- Did FedEx Just Deliver A Buying Opportunity?
- Autozone Shifts Back Into Rally-Mode, New Highs Are In Sight
Receive News & Ratings for Alliance Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alliance Pharma and related companies with MarketBeat.com's FREE daily email newsletter.